Details for Patent: 7,285,549
✉ Email this page to a colleague
Title: | Sulfamides and their use as endothelin receptor antagonists |
Abstract: | The invention relates to novel sulfamides and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and especially their use as endothelin receptor antagonists. |
Inventor(s): | Bolli; Martin (Allschwil, CH), Boss; Christoph (Allschwil, CH), Fischli; Walter (Allschwil, CH), Clozel; Martine (Saint-Louis, FR), Weller; Thomas (Binningen, CH) |
Assignee: | Actelion Pharmaceuticals Ltd. (Allschwil, CH) |
Filing Date: | Apr 07, 2006 |
Application Number: | 11/400,697 |
Claims: | 1. A compound selected from the group consisting of the compounds having the following structures: ##STR00535## ##STR00536## ##STR00537## ##STR00538## ##STR00539## ##STR00540## ##STR00541## ##STR00542## or a salt of such a compound. 2. The compound of claim 1, which has the following structure ##STR00543## or a salt of this compound. 3. The compound of claim 1, which has the following structure ##STR00544## or a salt of this compound. 4. The compound of claim 1, which has the following structure ##STR00545## or a salt of this compound. 5. The compound of claim 1, which has the following structure ##STR00546## or a salt of this compound. |